Vaccines containing bordetella pertussis antigen

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) A61K 39/095 (2006.01) A61K 39/10 (2006.01) A61K 39/116 (2006.01)

Patent

CA 2294348

A vaccinating conjugate comprises an antigen conjugated to a carrier selected from Bordetella pertussis fimbria, pertussis toxin, pertussis toxoid, and pertussis 69kD protein. The conjugate may also comprise a second antigen, different from the first. An oral vaccinating composition comprises Bordetella pertussis fimbria or fimbria-antigen conjugate.

L'invention concerne un conjugué de vaccination qui comprend un antigène conjugué à un support sélectionné entre la fimbria de Bordetella pertussis, la toxine de la coqueluche, l'anatoxine de coqueluche et la protéine 69kD de la coqueluche. Le conjugué peut aussi renfermer un second antigène, différent du premier. Une composition orale de vaccination comprend une fimbria de Bordetella pertussis ou un conjugué fimbria-antigène.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Vaccines containing bordetella pertussis antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccines containing bordetella pertussis antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines containing bordetella pertussis antigen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1536945

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.